Technical / White Paper
Orphan Drugs make all the difference to patients
Orphan drugs, those medications that are typically produced in small quantities for limited patient populations, are growing in importance worldwide. Once largely considered too costly to produce, given the limited number of patients affected by a particular disease, new technology and new breakthroughs in biopharma have changed the landscape, allowing more orphan drugs to be produced, thus saving countless lives that would otherwise be lost. But bringing an orphan drug to market has its own unique set of challenges. World Courier addresses the considerations that must be overcome.
